# Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

> **NCT00693095** · PHASE1 · COMPLETED · sponsor: **John Sampson** · enrollment: 23 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** CMV-ALT + CMV-DCs
- **BIOLOGICAL:** CMV-ALT + Saline

## Key facts

- **NCT ID:** NCT00693095
- **Lead sponsor:** John Sampson
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-12
- **Final completion:** 2015-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693095, "Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00693095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*